Furthermore, we found that ephrin-B2 immunoreactivity was significantly correlated with lymph node metastasis (p < 0.001) and clinical stage (p = 0.003; Table 1). The gene discussed is EFNB2; the disease is metastatic malignant neoplasm in the lymph nodes.